Mr Scott specialises in advising clients in the digital health, medical device, healthcare, software and pharmaceutical sectors with respect to regulatory compliance and litigation risk.

He regularly advises clients in relation to their applicable regulatory frameworks, routes to market, product safety, advertising, post-market obligations, product recall and regulatory enforcement issues.

Mr Scott also advises clients engaged in healthcare research and the development of emerging healthcare technologies such as mHealth applications and wearables on a wide range of regulatory issues.

He has considerable experience in healthcare-related litigation and recently represented a multinational healthcare company in high-profile Supreme Court proceedings relating to professional negligence.

Commenting on the appointment, managing partner Mark Homan said: “David’s appointment is another significant step for our firm, exemplifying our commitment to increasing and deepening our practice base.”